retatrutide nejm 2023 obesity trial ly3437943 A study of Lilly's weight loss drug in people with heart disease did not answer a crucial question — whether it reduces cardiovascular risk As an obesity medicine physician,
Pay in 4 interest-free payments of $6.54 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6



























